People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AeroRx Therapeutics, Inc. | — | Pharma | Series A | $10.4M | $30.7M | 2025 |
John Stuart Patton, Ph.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Stuart Patton, Ph.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tighe Reardon | 1 | 7 |
| Ahmet Tutuncu, M.D., Ph.D. | 1 | 1 |
| Heather Stuart Preston, M.D. | 1 | 1 |
| Jay B. Lichter, Ph.D. | 1 | 1 |
| Sanford Madigan, Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.